Harmony consumer study
118 participants,
14 days of feedback
Study results
What participants reported about our CBD spray
Harmony commissioned an independent consumer study of its CBD Oil Spray, conducted by Ayton Global Research Ltd in the UK. Participants reported their experiences over 14 days. Their responses describe personal experiences; they do not establish that the spray treats a condition or that everyone will experience the same results. Of the 118 participants, 107 answered all questions.
The Study
Independent
third party
14
days
118
participants
Ages
20 to 39
Men and
women
Conducted in the UK by Ayton Global Research Ltd
The Results
118 people participated in the 14-day study. The results shown are based on the 107 participants who answered all questions.
These are participant-reported survey results. The figures and charts reproduce the published study summary; they are not a comparison with an untreated or placebo group.
- 82%reported a soothing sensation
- 85%felt balanced, calm and collected
- 80%felt calm and focused
- 85%felt more relaxed
- 80%reported improved sleep and recovery
Feeling Calmer
73% of participants reported feeling calmer on day 1, increasing to 85% after 14 days.
Participants also described the spray as fresh and soothing.
| Day 1 | 73% |
|---|---|
| Day 14 | 85% |
| Day 7 | 67% |
|---|---|
| Day 14 | 80% |
Feeling More Rested
67% of participants reported feeling more rested after week 1, increasing to 80% after 14 days.
Participants also reported on relaxation in the evening and their perceived sleep and recovery.
Feeling More Relaxed
77% of participants reported feeling more relaxed after week 1, increasing to 85% after 14 days.
Participants also described feeling balanced, calm and collected during the day.
| Day 7 | 77% |
|---|---|
| Day 14 | 85% |
Use Reported in the Study
Most testers reported using
between 10 and 30 mg per day
This describes use reported in the study, not a recommended dose. Follow the current product label and instructions.
Participant Feedback
Selected comments from the published consumer study. Some are excerpts, marked with an ellipsis.
Individual experiences are not a guarantee of results. French versions are translations of the original English comments.
“I've never slept better than when I used this spray”
★★★★★
“Brilliant product and excited to buy it in the future! Highly recommend to friends and family.”
★★★★★
“I liked the taste, it helped me relax, and my mood was better after”
★★★★★
“I have had really good success with this spray. […]”
★★★★★
“Pleasant and refreshing taste. […]”
★★★★★
“Extremely impressed with this product! […]”
★★★★★
Explore the Spray Range
Further Reading
These publications cover different formulations, study populations and research questions. They provide background reading on CBD; their findings cannot be assumed to apply to Harmony sprays. A paper title may describe a research hypothesis or medical use under investigation, rather than an approved use or established benefit of our products.
- Dosage, Efficacy and Safety of Cannabidiol Administration in Adults: A Systematic Review of Human Trials.
- A systematic review of the antipsychotic properties of cannabidiol in humans.
- Cannabidiol reduces cigarette consumption in tobacco smokers: preliminary findings.
- Reasons for cannabidiol use: a cross-sectional study of CBD users, focusing on self-perceived stress, anxiety, and sleep problems.
- Cannabidiol as a Potential Treatment for Anxiety Disorders.
- The Safety and Comparative Effectiveness of Non-Psychoactive Cannabinoid Formulations for the Improvement of Sleep: A Double-Blinded, Randomized Controlled Trial.
- The endocannabinoid system of the skin. A potential approach for the treatment of skin disorders.
- Effects of Cannabidiol Supplementation on Skeletal Muscle Regeneration after Intensive Resistance Training.
- Evaluation of the effects of CBD hemp extract on opioid use and quality of life indicators in chronic pain patients: a prospective cohort study.
- Molecular and Biochemical Mechanism of Cannabidiol in the Management of the Inflammatory and Oxidative Processes Associated with Endometriosis.